We are proud to announce the selection of Dr. Reshma Ramracheya for an oral presentation at the prestigious Third European Association for the Study of Diabetes Incretin Study Group Meeting. Our Head of Pharmaceutical Operations will be discussing what is “known, new, controversial” in the incretin field so as to identify key questions that need to be addressed in clinical and fundamental science and propose key clinical trials.

Latest News
  • 05 February 2020 Our exceptional team in Romania is celebrating a decade of success!
  • 24 January 2020 CIDP hosted by the South African Medical Research Council.
  • 20 December 2019 Season's Greetings to Everyone!
Archives

Time Zone

Choose a centre